Literature DB >> 29684532

A complicated complex: Ion channels, voltage sensing, cell membranes and peptide inhibitors.

Alan H Zhang1, Gagan Sharma1, Eivind A B Undheim1, Xinying Jia1, Mehdi Mobli2.   

Abstract

Voltage-gated ion channels (VGICs) are specialised ion channels that have a voltage dependent mode of action, where ion conduction, or gating, is controlled by a voltage-sensing mechanism. VGICs are critical for electrical signalling and are therefore important pharmacological targets. Among these, voltage-gated sodium channels (NaVs) have attracted particular attention as potential analgesic targets. NaVs, however, comprise several structurally similar subtypes with unique localisations and distinct functions, ranging from amplification of action potentials in nociception (e.g. NaV1.7) to controlling electrical signalling in cardiac function (NaV1.5). Understanding the structural basis of NaV function is therefore of great significance, both to our knowledge of electrical signalling and in development of subtype and state selective drugs. An important tool in this pursuit has been the use of peptides from animal venoms as selective NaV modulators. In this review, we look at peptides, particularly from spider venoms, that inhibit NaVs by binding to the voltage sensing domain (VSD) of this channel, known as gating modifier toxins (GMT). In the first part of the review, we look at the structural determinants of voltage sensing in VGICs, the gating cycle and the conformational changes that accompany VSD movement. Next, the modulation of the analgesic target NaV1.7 by GMTs is reviewed to develop bioinformatic tools that, based on sequence information alone, can identify toxins that are likely to inhibit this channel. The same approach is also used to define VSD sequences, other than that from NaV1.7, which are likely to be sensitive to this class of toxins. The final section of the review focuses on the important role of the cellular membrane in channel modulation and also how the lipid composition affects measurements of peptide-channel interactions both in binding kinetics measurements in solution and in cell-based functional assays.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell membrane; Gating modifier toxins; Lipid binding; Receptor-ligand complex; Venom peptide; Voltage-gated ion channel

Mesh:

Substances:

Year:  2018        PMID: 29684532     DOI: 10.1016/j.neulet.2018.04.030

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  Manipulation of a spider peptide toxin alters its affinity for lipid bilayers and potency and selectivity for voltage-gated sodium channel subtype 1.7.

Authors:  Akello J Agwa; Poanna Tran; Alexander Mueller; Hue N T Tran; Jennifer R Deuis; Mathilde R Israel; Kirsten L McMahon; David J Craik; Irina Vetter; Christina I Schroeder
Journal:  J Biol Chem       Date:  2020-03-05       Impact factor: 5.157

2.  RCSB Protein Data Bank: Enabling biomedical research and drug discovery.

Authors:  David S Goodsell; Christine Zardecki; Luigi Di Costanzo; Jose M Duarte; Brian P Hudson; Irina Persikova; Joan Segura; Chenghua Shao; Maria Voigt; John D Westbrook; Jasmine Y Young; Stephen K Burley
Journal:  Protein Sci       Date:  2019-11-29       Impact factor: 6.725

3.  Secreted Cysteine-Rich Repeat Proteins "SCREPs": A Novel Multi-Domain Architecture.

Authors:  Michael Maxwell; Eivind A B Undheim; Mehdi Mobli
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

Review 4.  The NaV1.7 Channel Subtype as an Antinociceptive Target for Spider Toxins in Adult Dorsal Root Ganglia Neurons.

Authors:  Tânia C Gonçalves; Evelyne Benoit; Michel Partiseti; Denis Servent
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

5.  Two for the Price of One: Heterobivalent Ligand Design Targeting Two Binding Sites on Voltage-Gated Sodium Channels Slows Ligand Dissociation and Enhances Potency.

Authors:  Alicia Peschel; Fernanda C Cardoso; Andrew A Walker; Thomas Durek; M Rhia L Stone; Nayara Braga Emidio; Philip E Dawson; Markus Muttenthaler; Glenn F King
Journal:  J Med Chem       Date:  2020-10-20       Impact factor: 7.446

6.  Two Novel Peptide Toxins from the Spider Cyriopagopus longipes Inhibit Tetrodotoxin-Sensitive Sodium Channels.

Authors:  Qingfeng Zhang; Yuxin Si; Li Yang; Li Wang; Shuijiao Peng; Yiming Chen; Minzhi Chen; Xi Zhou; Zhonghua Liu
Journal:  Toxins (Basel)       Date:  2020-08-19       Impact factor: 4.546

7.  Aspartic Acid Isomerization Characterized by High Definition Mass Spectrometry Significantly Alters the Bioactivity of a Novel Toxin from Poecilotheria.

Authors:  Stephen R Johnson; Hillary G Rikli
Journal:  Toxins (Basel)       Date:  2020-03-25       Impact factor: 4.546

8.  Engineering Gain-of-Function Analogues of the Spider Venom Peptide HNTX-I, A Potent Blocker of the hNaV1.7 Sodium Channel.

Authors:  Yunxiao Zhang; Qiuchu Yang; Qingfeng Zhang; Dezheng Peng; Minzhi Chen; Songping Liang; Xi Zhou; Zhonghua Liu
Journal:  Toxins (Basel)       Date:  2018-09-04       Impact factor: 4.546

9.  Elucidating the Lipid Binding Properties of Membrane-Active Peptides Using Cyclised Nanodiscs.

Authors:  Alan H Zhang; Ingrid A Edwards; Biswa P Mishra; Gagan Sharma; Michael D Healy; Alysha G Elliott; Mark A T Blaskovich; Matthew A Cooper; Brett M Collins; Xinying Jia; Mehdi Mobli
Journal:  Front Chem       Date:  2019-04-16       Impact factor: 5.221

Review 10.  Spider Knottin Pharmacology at Voltage-Gated Sodium Channels and Their Potential to Modulate Pain Pathways.

Authors:  Yashad Dongol; Fernanda Caldas Cardoso; Richard J Lewis
Journal:  Toxins (Basel)       Date:  2019-10-29       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.